Andra AP fonden purchased a new position in Teleflex Incorporated (NYSE:TFX – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund purchased 10,300 shares of the medical technology company’s stock, valued at approximately $1,833,000.
A number of other hedge funds also recently modified their holdings of the stock. Janus Henderson Group PLC raised its holdings in shares of Teleflex by 2.8% in the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after purchasing an additional 147,147 shares during the period. State Street Corp raised its holdings in shares of Teleflex by 1.0% in the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock worth $508,757,000 after purchasing an additional 21,291 shares during the period. Geode Capital Management LLC raised its holdings in shares of Teleflex by 0.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock worth $278,676,000 after purchasing an additional 5,746 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in shares of Teleflex by 0.4% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company’s stock worth $105,749,000 after purchasing an additional 1,884 shares during the period. Finally, Point72 Asset Management L.P. raised its holdings in shares of Teleflex by 31.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock worth $100,768,000 after purchasing an additional 96,958 shares during the period. Institutional investors own 95.62% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts recently commented on TFX shares. Citizens Jmp cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Truist Financial lowered their price target on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a report on Monday, March 3rd. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Wells Fargo & Company lowered their target price on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a report on Friday, February 28th. Finally, Royal Bank of Canada cut shares of Teleflex from an “outperform” rating to a “sector perform” rating and lowered their target price for the company from $220.00 to $155.00 in a report on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Teleflex presently has a consensus rating of “Hold” and an average price target of $182.63.
Teleflex Trading Up 2.9 %
Teleflex stock opened at $140.24 on Monday. The stock has a market cap of $6.50 billion, a P/E ratio of 27.88, a PEG ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a fifty-two week low of $128.55 and a fifty-two week high of $249.90. The firm’s fifty day moving average price is $171.13 and its 200-day moving average price is $201.04. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.
Teleflex (NYSE:TFX – Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping the consensus estimate of $3.86 by $0.03. The firm had revenue of $795.40 million for the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Equities research analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.
Teleflex Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, March 7th will be issued a $0.34 dividend. The ex-dividend date is Friday, March 7th. This represents a $1.36 annualized dividend and a dividend yield of 0.97%. Teleflex’s payout ratio is currently 95.77%.
Teleflex Company Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Featured Articles
- Five stocks we like better than Teleflex
- What Is WallStreetBets and What Stocks Are They Targeting?
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Stock Analyst Ratings and Canadian Analyst Ratings
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Stock Average Calculator
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.